Jaguar Health, Inc. 8-K — AI Bull & Bear Analysis

Jaguar Health's 8-K confirms the resolution of its annual meeting after multiple adjournments, resulting in the approval of a new director, the ratification of auditors, and a critical equity issuance agreement. While the company now has the legal authority to proceed with its capital raise, the high level of broker non-votes and the nature of the C/M Capital deal highlight a tension between immediate survival and long-term shareholder value.